SEOUL – The government of South Korea has designated a new batch of 36 pharma companies and bioventures it deems innovative and therefore eligible to receive state support under a scheme designed to bolster original R&D.
Korea Chooses New Group Of Innovators For R&D Support
South Korea’s Ministry of Health and Welfare has unveiled a list of companies that will be designated as innovative pharma firms for the next three years and thus eligible to receive financial and tax incentives to boost their R&D activities.